Cours actuels de Nuvectis Pharma, Inc. - Common Stock

Bourse	Ticker	Devise	Dernier échange	Cours	Variation journalière	Variation journalière %
NASDAQ	NVCT	USD	05.02.2025 23:11	7,00 USD	6,99 USD	0,14 %

Performance

Jour	Semaine	Mois	3 mois	6 mois	1 an	5 ans
0,00 %	9,20 %	24,33 %	-6,17 %	-0,43 %	1,30 %	115,38 %

Profil de l'entreprise pour Nuvectis Pharma, Inc. - Common Stock Action

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

Données de l'entreprise

Nom Nuvectis Pharma, Inc. - Common Stock

Société Nuvectis Pharma, Inc.

Symbole NVCT

Site web https://www.nuvectis.com

Marché d'origine

NASDAQ

ISIN US67080T1088

Type de titre Action

Secteur Healthcare

Industrie Biotechnology

PDG Mr. Ron Bentsur M.B.A.

Capitalisation boursière 128 Mio

Pays États-Unis d'Amérique

Devise USD

Employés 0,0 T

Adresse 1 Bridge Plaza, 07024 Fort Lee

Date d'introduction en bourse 2022-02-04

Ticker Symbols

Name	Symbol
NASDAQ	NVCT

More Shares

Investors who Nuvectis Pharma, Inc. - Common Stock hold also have the following shares in their portfolio:

FIRST TRUST INDXX GLOBAL AGRICULTURE ETF ETF

NATURGY ENERGY ADR1/5/E01 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog